ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.650
-0.050 (-2.94%)
At close: May 20, 2025, 4:00 PM
1.650
0.00 (0.00%)
After-hours: May 20, 2025, 4:00 PM EDT

ESSA Pharma Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Net Income
-28.5-28.54-26.58-35.1-36.81-23.45
Upgrade
Depreciation & Amortization
0.090.090.120.120.110.11
Upgrade
Loss (Gain) From Sale of Investments
-0.9-0.92-0.670.07--
Upgrade
Stock-Based Compensation
8.486.545.017.899.487.52
Upgrade
Other Operating Activities
0.610.530.01-0.2-0.140.07
Upgrade
Change in Accounts Receivable
0.05-0.03-0.130.48-0.160.09
Upgrade
Change in Accounts Payable
-2.49-0.241.24-1.632.67-0.05
Upgrade
Change in Income Taxes
------0.02
Upgrade
Change in Other Net Operating Assets
0.21-0.151.230.37-0.56-1.26
Upgrade
Operating Cash Flow
-22.43-22.72-19.78-28-25.42-16.98
Upgrade
Investment in Securities
16.9791.79-3.53-53.05-35.03-22.01
Upgrade
Other Investing Activities
----0.010.27
Upgrade
Investing Cash Flow
16.9791.79-3.53-53.05-35.01-21.74
Upgrade
Long-Term Debt Repaid
---0.14-0.13-0.1-4.01
Upgrade
Net Debt Issued (Repaid)
---0.14-0.13-0.1-4.01
Upgrade
Issuance of Common Stock
0.090.930.070.39151.3249.33
Upgrade
Other Financing Activities
-----9.23-3.54
Upgrade
Financing Cash Flow
0.090.93-0.070.25141.9941.78
Upgrade
Foreign Exchange Rate Adjustments
00.0100.05-0.06-0.06
Upgrade
Net Cash Flow
-5.3770.01-23.37-80.7581.53
Upgrade
Free Cash Flow
-22.43-22.72-19.78-28-25.42-16.98
Upgrade
Free Cash Flow Per Share
-0.51-0.51-0.45-0.64-0.66-0.76
Upgrade
Cash Interest Paid
-----0.03
Upgrade
Levered Free Cash Flow
-16.61-15.2-12.62-15.88-11.68-8.92
Upgrade
Unlevered Free Cash Flow
-16.61-15.2-12.62-15.87-11.67-8.78
Upgrade
Change in Net Working Capital
2.370.32-2.340.78-1.961.71
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q